The Jackson Heart Study of Cardiovascular Disease Among African Americans

Study acronym: JHS
StatusActive, Not Recruiting
PhaseNot specified
Started

Record status This record was last updated July 9, 2025 (before its estimated August 12, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: details revised at 2 of 11 entriesv12
  2. Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Enrollment target: estimated 3000 to confirmed 5306
    • Study description shortened, about 61 words
    v11
  3. Primary and study completion dates: Apr 12, 2025 to Aug 12, 2025v10
  4. Primary and study completion dates: Apr 12, 2023 to Apr 12, 2025
    • Study description shortened, about 12 words
    v9
  5. Trial status: Suspended to Enrolling by Invitationv8 Show 4 more changesShow less
    • Enrollment target: 5306 to 3000
    • Primary and study completion dates: Aug 2024 to Apr 12, 2023
    • Start date: Sep 2000 to Sep 19, 2000
    • Study site revised
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Active, Not Recruiting to Suspended Sponsor's reason: COVID-19 outbreak
    • Study sites: 3 to 1
    • Study description shortened, about 4 words
    v7
  2. Primary and study completion dates: Aug 2024
    • Study description shortened, about 37 words
    • Study title revised
    v6
  3. Start date: Oct 1996 to Sep 2000v5 Show 5 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 5307 to confirmed 5306
    • Study sites: 1 to 3
    • Eligibility criteria expanded, about 7 words
    • Study title shortened, about 1 word
  4. Site contact updated
    • Publications: 10 to 11
    • Study description expanded, about 2 words
    v4
  5. Enrollment target: 5307v3 Show 4 more changesShow less
    • Study completion date: May 2013 to not stated
    • Study description shortened, about 69 words
    • Study title expanded, about 7 words
    • Eligibility criteria expanded, about 1 word
  6. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
National Heart, Lung, and Blood Institute (NHLBI)
137 trials monitored
See 6 trials at risk
Heart Disease
8,870 trials monitored
See 440 trials at risk
Diabetes
5,141 trials monitored
See 246 trials at risk
Stroke
3,560 trials monitored
See 169 trials at risk
and 3 more diseases
This is a prospective study of the environmental and genetic factors that influence the development of cardiovascular disease (CVD) in African American adults. The cohort is a collaboration among multiple institutions (Jackson State University, Mississippi State Department of Health, Tougaloo College, and the University of Mississippi Medical Center), NIMHD, and NHLBI.
Trial Details
NCT Number NCT00005485
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions
(from sponsor)		 Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Coronary Disease, Hypertension, Cerebrovascular Disorders
Related terms Atherosclerosis, Cardiovascular Diseases, Cerebrovascular Disorders, Coronary Disease, Diabetes Mellitus, Heart Diseases, Heart Failure, Hypertension, Renal Insufficiency, Chronic, Stroke
Enrollment 5,306 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov